Sangamo Biosciences Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Sangamo Biosciences Inc
CIK #0001001233
EDGAR Form CIK 2011 - 2026
10-K [0001001233]
10-Q [0001001233]
3 [0001001233]
4 [0001001233]
5 [0001001233]
8-K [0001001233]
SC 13G [0001001233]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Sangamo Therapeutics Inc [2026-05-15]
Biogen Inc Sangamo Therapeutics Inc [2020-04-17]
Wasatch Advisors Inc Sangamo Therapeutics Inc [2020-02-10]
BlackRock Inc Sangamo Therapeutics Inc [2020-02-06]
Wellington Management Group LLP Sangamo Therapeutics Inc [2020-01-28]
State Street Corp Sangamo Therapeutics Inc [2019-02-13]
FMR LLC Sangamo Therapeutics Inc [2018-02-13]
Vanguard Group Inc Sangamo Therapeutics Inc [2018-02-09]
Adage Capital Partners GP LLC Sangamo Therapeutics Inc [2017-06-02]
Baker Bros Advisors LP Sangamo Biosciences Inc [2016-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
Dubois-Stringfellow Nathalie
Sangamo Therapeutics Inc
Davis Gregory D
Macrae Sandy
Jain Nikunj
Willoughby Scott B
Duraibabu Prathyusha
Parker H Stewart
Smith Karen L
Meyers James R
Markels John
Horn Margaret A
Hillan Kenneth
Carey Robert
Beers Courtney
Pooler Amy
Fontenot Jason D
McClung David Mark
Biogen MA Inc
Biogen Inc
Ramelmeier Rolf Andrew
Schott Robert J
Zakrzewski Joseph S
Ramasastry Saira
Loeb Gary
Lee Sung
Boissel Stephane
Dilly Stephen George
Woolfson Adrian
Yi Kathy
Turner Heather D
Conner Edward R
Jeffs Roger
Mento Steven J
Herberts Curt A III
Ringo William R
Lanphier Edward O II
Wolff Henry Ward
Cleveland Paul B
ANDO Dale G
Nichol Geoffrey
Larson John William
Gregory Philip D
Kolchinsky Peter
RA Capital Healthcare Fund LP
RA Capital Management LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-25 Tax withheld 5,119 $0.47 2,406
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-25 Tax withheld 5,119 $0.47 2,406
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-25 Tax withheld 12,354 $0.47 5,806
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-25 Tax withheld 33,637 $0.47 15,809
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-25 Tax withheld 12,354 $0.47 5,806
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-24 Tax withheld 1,650 $0.47 776
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-24 Tax withheld 5,291 $0.47 2,487
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-24 Tax withheld 666 $0.47 313
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-24 Tax withheld 2,063 $0.47 970
Sangamo Therapeutics Inc SGMO
Common Stock
2026-02-24 Tax withheld 832 $0.47 391
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 36,676 $0.40 14,670
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 7,721 $0.40 3,088
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 7,721 $0.40 3,088
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 102,950 $0.40 41,180
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 36,676 $0.40 14,670
Sangamo Therapeutics Inc SGMO
Common Stock
2026-01-22 Tax withheld 36,676 $0.40 14,670
Sangamo Therapeutics Inc SGMO
Common Stock
2025-11-24 Tax withheld 2,035 $0.42 855
Sangamo Therapeutics Inc SGMO
Common Stock
2025-11-24 Tax withheld 7,488 $0.42 3,145
Sangamo Therapeutics Inc SGMO
Common Stock
2025-11-24 Tax withheld 578 $0.42 243
Sangamo Therapeutics Inc SGMO
Common Stock
2025-11-24 Tax withheld 2,544 $0.42 1,068
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com